Selection of complementary single-variable domains for building monoclonal antibodies to native proteins

Nucleic Acids Research

Volumn 37, Issue 5, 2009, Pages

  Tanaka, Tomoyuki ^a   Rabbitts, Terence H ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; LUCIFERASE; ONCOPROTEIN; PROTEIN LMO2; RAS PROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG; MONOCLONAL ANTIBODY; PROTEIN; PROTEIN P21;

ANIMAL CELL; ANTIBODY AFFINITY; ANTIBODY COMBINING SITE; ANTIBODY ISOLATION; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; IMMUNOGLOBULIN VARIABLE REGION; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CELL STRAIN 3T3; CHEMISTRY; CHO CELL; CRICETULUS; GENE LIBRARY; GENETICS; HAMSTER; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; MOUSE; PROTEIN ENGINEERING; PROTEIN TERTIARY STRUCTURE;

ANIMALS; ANTIBODIES, MONOCLONAL; CHO CELLS; CRICETINAE; CRICETULUS; GENE LIBRARY; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MICE; NIH 3T3 CELLS; ONCOGENE PROTEIN P21(RAS); ONCOGENE PROTEINS; PROTEIN ENGINEERING; PROTEIN STRUCTURE, TERTIARY; PROTEINS;

EID: 63249110005     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp069     Document Type: Article

References (23)

1. Kohler,G. and Milstein,C. (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, 256, 495-497.
2. Winter,G., Griffiths,A.D., Hawkins,R.E. and Hoogenboom,H.R. (1994) Making antibodies by phage display technology. Annu. Rev. Immunol. 12, 433-455.
3. Ward,E.S., Gussow,D., Griffiths,A.D., Jones,P.T. and Winter,G. (1989) Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature, 341, 544-546.
4. Holliger,P. and Hudson,P.J. (2005) Engineered antibody fragments and the rise of single domains. Nat. Biotechnol, 23, 1126-1136.
5. Harlow, E. and Lane, D. (1999) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, New York, USA (CSHL Press).
6. Morrison,S.L., Johnson,M.J., Herzenberg,L.A. and Oi,V.T. (1984) Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains. Proc. Natl Acad. Sci. USA, 81, 6851-6855.
7. Neuberger,M.S., Williams,G.T., Mitchell,E.B., Jouhal,S.S., Flanagan,J.G. and Rabbitts,T.H. (1985) A hapten-specific chimaeric IgE antibody with human physiological effector function. Nature, 314, 268-270.
8. Jones,P.T., Dear,P.H., Foote,J., Neuberger,M.S. and Winter,G. (1986) Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature, 321, 522-525.
9. Fleisher,T.A., Dorman,S.E., Anderson,J.A., Vail,M., Brown,M.R. and Holland,S.M. (1999) Detection of intracellular phosphorylated STAT-1 by flow cytometry. Clin. Immunol., 90, 425-430.
10. Holt,L.J., Herring,C., Jespers,L.S., Woolven,B.P. and Tomlinson,I.M. (2003) Domain antibodies: Proteins for therapy. Trends Biotechnol, 21, 484-490.
11. Tanaka,T., Lobato,M.N. and Rabbitts,T.H. (2003) Single domain intracellular antibodies: A minimal fragment for direct in vivo selection of antigen-specific intrabodies. J. Mol. Biol., 331 1109-1120.
12. Tse,E., Lobato,M.N., Forster,A., Tanaka,T., Chung,G.T.Y. and Rabbitts,T.H. (2002) Intracellular antibody capture technology: application to selection of single chain Fv recognising the BCR-ABL oncogenic protein. J. Mol. Biol., 317, 85-94.
13. Tanaka,T. and Rabbitts,T.H. (2003) Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation. EMBO J., 22, 1025-1035.
14. Nam,C.H., Lobato,M.N., Appert,A., Drynan,L.F., Tanaka,T. and Rabbitts,T.H. (2008) An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions. Oncogene, 27, 4962-4968.
15. de Wildt,R.M., Mundy,C.R., Gorick,B.D. and Tomlinson,I.M. (2000) Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat. Biotechnol, 18, 989-994.
16. Tanaka,T., Chung,G.T.Y., Forster,A., Lobato,M.N. and Rabbitts,T.H. (2003) De novo production of diverse intracellular antibody libraries. Nucleic Acids Res., 31, e23.
17. Visintin,M., Tse,E., Axelson,H., Rabbitts,T.H. and Cattaneo,A. (1999) Selection of antibodies for intracellular function using a two-hybrid in vivo system. Proc. Natl Acad. Sci. USA, 96, 11723-11728.
18. Tanaka,T., Williams,R.L. and Rabbitts,T.H. (2007) Tumour prevention by a single antibody domain inhibiting binding of signal transduction molecules to activated RAS. EMBO J., 26, 3250-3259.
19. Warren,A.J., Colledge,W.H., Carlton,M.B.L., Evans,M.J., Smith,A.J.H. and Rabbitts,T.H. (1994) The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell, 78, 45-58.
20. Tse,E. and Rabbitts,T.H. (2000) Intracellular antibody-caspase mediated cell killing: A novel approach for application in cancer therapy. Proc. Natl Acad. Sci. USA, 97, 12266-12271.
21. Nahar,I.K., Shojania,K., Marra,C.A., Alamgir,A.H. and Anis,A.H. (2003) Infliximab treatment of rheumatoid arthritis and Crohn's disease. Ann. Pharmacother, 37, 1256-1265.
22. Reff,M.E., Carner,K., Chambers,K.S., Chinn,P.C., Leonard,J.E., Raab,R., Newman,R.A., Hanna,N. and Anderson,D.R. (1994) Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood, 83, 435-445.
23. Carter,P., Presta,L., Gorman,C.M., Ridgway,J.B., Henner,D., Wong,W.L., Rowland,A.M., Kotts,C., Carver,M.E. et al. (1992) Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc. Natl Acad. Sci. USA, 89, 4285-4289.